Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression-linked promoter selection (ELiPS) engineers short, strong ubiquitous promoters for gene therapy applications.

bioRxiv : the preprint server for biology·2026
Same author

Optogenetic WNT signaling drives germ layer self-organization in a human gastruloid model.

bioRxiv : the preprint server for biology·2026
Same author

Directed evolution of novel AAV capsids for enhanced delivery to mouse and human Schwann cells.

Molecular therapy. Nucleic acids·2026
Same author

How artificial intelligence is reengineering protein engineering.

Science (New York, N.Y.)·2026
Same author

Structural ontogeny of protein-protein interactions.

Science (New York, N.Y.)·2026
Same author

Hydrogen Spillover-Mediated Spatial Decoupling Process Boosts Syngas Conversion to Higher Oxygenates.

Journal of the American Chemical Society·2025
Same journal

Intrinsically disordered regions in eukaryotic mRNA decay pathways.

Trends in biochemical sciences·2026
Same journal

A unified mechanism of phosphate export across eukaryotes through EXS domain-containing proteins.

Trends in biochemical sciences·2026
Same journal

Drugging the proteome via large-scale chemoproteomics.

Trends in biochemical sciences·2026
Same journal

Peptideins: Navigating the gray zone of the proteome.

Trends in biochemical sciences·2026
Same journal

A metabolon channels nicotine biosynthesis.

Trends in biochemical sciences·2026
Same journal

Better call chaperone.

Trends in biochemical sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

4.5K

Computationally guided AAV engineering for enhanced gene delivery.

Jingxuan Guo1, Li F Lin2, Sydney V Oraskovich3

  • 1California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA 94720, USA.

Trends in Biochemical Sciences
|March 26, 2024
PubMed
Summary
This summary is machine-generated.

Computational approaches, including machine learning, are enhancing adeno-associated virus (AAV) gene therapy vectors. This research explores how designed AAV libraries improve delivery efficiency for genetic and non-genetic disorders.

Keywords:
AAV librariesancestral sequence reconstructiondirected evolutionmachine learningnext-generation sequencingprotein engineering

More Related Videos

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

28.5K
AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
09:59

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

2.7K

Related Experiment Videos

Last Updated: Jun 29, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

4.5K
Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

28.5K
AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
09:59

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

2.7K

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Bioinformatics

Background:

  • Adeno-associated viruses (AAVs) are promising gene delivery vehicles for treating genetic and non-genetic disorders.
  • Current AAV therapies require improved delivery efficiency and targeting for enhanced safety and efficacy.

Purpose of the Study:

  • To review the role of computationally designed AAV libraries in directed evolution.
  • To highlight methods combining next-generation sequencing (NGS) and machine learning (ML) for AAV engineering.

Main Methods:

  • Harnessing next-generation sequencing (NGS) data.
  • Utilizing machine learning (ML) algorithms for AAV variant design.
  • Employing directed evolution strategies with computational libraries.

Main Results:

  • Computationally designed AAV libraries facilitate the generation of novel functional AAV capsids.
  • Integration of NGS and ML accelerates the discovery of improved AAV vectors.
  • Advancements in AAV engineering are pushing the boundaries of gene therapy.

Conclusions:

  • Computational design and directed evolution are key to advancing AAV-based gene therapies.
  • Machine learning and NGS integration offer powerful tools for optimizing AAV vector performance.
  • Improved AAV vectors hold significant potential for treating a wider range of diseases.